ABSTRACT
Neonates who contract infection caused by herpes simplex virus (HSV) are at substantial risk of death, and survivors often have substantial longterm sequelae. More than 90% of neonatal HSV infections are contracted from infected mothers at delivery (1). In addition to neonatal infection, potential morbidity attributable to maternal gestational genital herpes infection include premature delivery, intrauterine growth retardation (IUGR), and congenital infection (1). Understanding the epidemiology and manifestations of gestational and neonatal HSV infections is critical to the development of effective management strategies.
